SPVN-30

N/A

Report date: 2024/09/06 16:56:31

Base Information

Drug NameSPVN-30
Drug Alias NameSPVN30SPVN-30SPVN06/20SPVN-06/20SPVN20/06 +[6] 
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSparingVision Inc
China Registration ClassN/A

Develop Information

Active CompaniesSparingVision Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A